Atlas Trials

Assessment Study to Evaluate Specific Immune Response in Locally Advanced Cervix Cancer After Radio-chemotherapy

Clinical trial NCT03255252 · TERMINATED

Trial details

NCT number
NCT03255252
Sponsor
Institut du Cancer de Montpellier - Val d'Aurelle
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Cervical Cancer
Start date
2017-07-15
Primary completion
2022-06-16
Enrollment
29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.